News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
160 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (15769)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3357)
June (969)
Day
1 (213)
2 (187)
3 (160)
4 (140)
5 (74)
7 (52)
8 (140)
9 (3)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
Day
1
2
3
4
5
7
8
9
Cancer
ASCO’s biggest winners showcased a new era of cancer innovation
Revolution Medicines stole the show at the 2026 American Society of Clinical Oncology meeting as full data from its pancreatic cancer drug lived up to expectations, while Summit and Akeso proved the PD-(L)1/VEGF mechanism and Eli Lilly showed that its in vivo CAR T bet is paying off.
June 3, 2026
·
7 min read
·
Heather McKenzie
CAR-T
Legend soars on ‘best-in-class,’ ‘best-in-disease’ in vivo CAR T in early lymphoma study
All six non-Hodgkin lymphoma patients on Legend Biotech’s CAR T therapy responded to treatment—findings that could make the biotech an attractive takeover target, according to analysts at Oppenheimer.
June 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
June 3, 2026
·
4 min read
Press Releases
Lilly to spotlight growing hematology portfolio at 2026 European Hematology Association (EHA) Annual Meeting
June 3, 2026
·
17 min read
Press Releases
AvenCell Therapeutics to Report Phase 1a Results of First-in-Class Switchable Allogeneic CD123 CAR-T Therapy for AML in Late-Breaking oral presentation at EHA 2026
June 3, 2026
·
2 min read
Press Releases
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
June 3, 2026
·
4 min read
Press Releases
Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum
June 3, 2026
·
5 min read
Press Releases
Luminopia Announces First International Licensing Agreement with ROHTO Pharmaceutical to Launch Pediatric Amblyopia Treatment in Japan
June 3, 2026
·
5 min read
Press Releases
Moonlight Therapeutics Initiates Phase I Clinical Trial (SURVEYOR) of MOON101 for Peanut Allergy
June 3, 2026
·
4 min read
Press Releases
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities
June 3, 2026
·
5 min read
Previous
2 of 16
Next
